INBRAIN Neuroelectronics’ Post

Looking forward to talk about AI applications in the context of BCI therapeutics! How can AI+graphene be used to deliver high precision therapies for Parkinson's Disease? Come see us and talk to us!

CrystalsFirst announces its generative AI extension - FragAI - as part of the MAGNET platform. CrystalsFirst's MAGNET platform overcomes current limitations of small molecule drug discovery. Our proprietary technology SmartSoak® detects molecular magnets and generative AI identifies novel molecules and druggable binding pockets.    Applications and features of FragAI:  - Intellectual Property shield and protection - Ligand- and structure-based workflows - Fragment evolution for FBDD - Hit-to-lead and lead optimization tailoring the target product profile - Compatible with X-ray crystallography and CryoEM derived structures #generativeAI #SBDD #FBDD #drugdiscovery #crystallography #innovation

Exciting news in the world of drug discovery! NVIDIA has unveiled BioNeMo, a generative AI platform capable of analyzing DNA sequences, predicting protein shapes, and determining cell functions based on RNA. With the ability to simplify and accelerate model training on proprietary data, BioNeMo has the potential to transform how we approach disease treatment. From personalized medicine to drug optimization, this platform is poised to make a significant impact on the industry. By democratizing AI-driven drug discovery, BioNeMo empowers researchers worldwide to make breakthroughs that benefit patients and society as a whole. Learn more about this groundbreaking technology and its potential to revolutionize the field. #drugdiscovery #AI #BioNeMo #innovation

Looking forward to the conversation tomorrow about AI’s transformative and diverse impact on healthcare in the coming years!

Challenge yourself with Cytocast's AI & Drug Development Quiz!

Exploring Aiforia Technologies’ new toxpath module at #USCAP2024! GLP-compliant, AI-powered analysis for toxpath is here 🧪 From counting kidney glomeruli to precise differentiation, Aiforia is making pathologists' lives easier and quantification sharper. #Aiforia #DigitalPathology

Discovering Aiforia Technologies' leap into toxpath with their new GLP-compliant module at #USCAP2024! 🌟 Met with the Aiforia team to dive into how AI is revolutionizing toxicological pathology. With capabilities to perform primary reads, image analysis, and AI-driven models, #Aiforia is changing the game. 🧬 Imagine counting kidney glomeruli, differentiating sclerotic from viable ones, all streamlined by AI. It’s not just innovation; it’s making life easier for pathologists with precise quantification. Embracing AI in toxpath, we're stepping into a future where technology enhances our insights. 🚀 #DigitalPathology #ToxPathInnovation

How does Artificial Intelligence enable researchers to make data-driven decisions in the field of drug discovery? Incorporating AI into live-cell imaging and analysis workflows enables robust quantification of a wide range of cellular models, enabling these data-driven decisions and creating a deeper understanding of disease at a granular level. Learn more: https://ow.ly/AQCL50Q3W6I #livecellimaging #livecellanalysis #artificialintelligence #cellhealth

Recently, Google DeepMind and Isomorphism Lab released an AI model that shocked the industry - Alphafold 3, and introduced its powerful functions. The title of the paper published in the journal Nature clearly states that Alphafold3 can predict the structure and interactions of all living molecules with unprecedented accuracy. This means that structural and interaction data for proteins, DNA, RNA, small molecule ligands, and more can be obtained with just a click of the mouse. I have discussed this with several friends who use AI to design antibodies. They generally believe that AI is indeed very helpful in design, but more structural data is needed to improve it. In addition, functional verification is also essential. Some AI users have already used Gator to verify and screen AI-designed antibodies. As demonstrated in the workflow below, the HT GatorPro is the only BLI with 32-high frequency channels with minimal hands-on time and full automation: Quantitation: 1152 samples/2 hrs Kinetics assay: 96 samples/hr Epitope binning/Receptor Blocking: 96 samples/hr #AI # GatorPro #BLI #Antibody #Protein #DNA #RNA

Converging Innovations to Break Barriers in Neural Drug Discovery Watch our webinar to learn about how Tessara's RealBrain technology and the F.A.S.T. liquid handler has enabled the production of 3D organotypic neural models in a 96-well format, ensuring high reproducibility and scalability for efficient drug development. Learn more: https://hubs.ly/Q02G9CRH0 #DrugDevelopment #LiquidHandling #FASTbyFormulatrix #RealBrain #Tessara #Formulatrix